HomeStay Declares Appointment of Philippa Lewis as the Interim CEO

HSC

HomeStay Care Limited (ASX: HSC) is a home senior care services provider in Australia. On 11 March 2019, the company has come up with an update regarding the appointment of Philippa Lewis as an interim CEO, commencing immediately.

Mr Wayne Cahill, HomeStay Chairman, said that the company is pleased to appoint Philippa as interim CEO, as she brings a wealth of industry and strategic experience at a critical time in the Company’s growth stage. He said that Philippa is well-connected and has exceptional skills to support the company’s strategy execution. The company has technology solutions well-matched to Australians wanting to stay in their homes, and the importance of this is echoed in terms of reference to the current Royal Commission into Aged Care.

Philippa stated that she is delighted to be joining the company. She feels that the industry is vibrant and growing and the HomeStay applications are vast and appropriate. Helping older Australians to say at home for as long as possible and being independent and safe is an extremely important viewpoint. The company’s one of a kind solution will confirm that this is possible for many more people. She said that she would be pleased to be able to contribute to that very bright future and support of all older Australians.

Philippa has been involved on an initial 3-month contract to work closely with the company’s team to ensure continued product refinement, create strong commercial relationships and successfully continue to deliver the business metrics. The Company is also undertaking an extensive CEO search assisted by a known international recruitment agency.

Philippa has global health and aged care industry experience and has founded and managed multiple private and publicly listed start-up enterprises. She has extensive experience in product development and commercialising medical devices, disruptive digital technologies as well as AI. She has over 25 years of health, aged care and medtech sector experience and is currently an advisor and nonexecutive director to numerous aged care and disability organisations in the medtech and biotech space including VisualAI Pty Ltd, an artificial Intelligence medical device company as well as CareVision Pty Ltd, a software company in the aged, disability homecare sector.

On the price-performance front, the stock has posted the YTD return of -16.67%. The company also posted returns of -26.83% and -23.08% over the past six months & three-months period respectively. At the time of writing (11 March 2019, AEST 01:48 PM), the stock of the company is trading at a price of $0.030, performing flat during the day’s trade with a market capitalisation of ~$ 20.85 Mn. The stock opened the day at $ 0.030, which was also the day’s high, with an average daily volume of ~ 500,000. It had a 52-week high price of $ 0.048 and a 52 weeks low price of $ 0.024, with an average volume of, 370,649 approximately.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Top 25 Dividend Stocks To Consider

People prefer a dividend stock in their portfolio as it possesses the feature of compounding. Compounding means that the earning which is generated through these dividend stock will get reinvested and will eventually create earnings from earning. More precisely, the dividend generated from these dividend stock will get reinvested to buy another set of a share of the dividend stock which results in giving a higher dividend.

Click here to download your top 25 dividend stocks report!

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here